Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications-Reference-Cited by-同舟云学术

Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications

Published:2021-11 Issue: Volume:92 Page:59-66
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Antonini Angelo,Odin Per,Schmidt Peter,Cubillos Fernando,Standaert David G.^ORCID,Henriksen Tove,Jimenez-Shahed Joohi,Alobaidi Ali^ORCID,Jalundhwala Yash J.^ORCID,Bao Yanjun^ORCID,Zamudio Jorge^ORCID,Parra Juan Carlos^ORCID,Kukreja Pavnit,Onuk Koray,Skalicky Anne M.,Kleinman Leah,Jones Eddie^ORCID,Metz Sharon,Fernandez Hubert H.

Funder

AbbVie Inc

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference30 articles.

1. The Parkinson pandemic—a call to action;Dorsey;JAMA Neurol,2018

2. Early DEtection of wEaring off in Parkinson disease: the DEEP study;Stocchi;Park. Relat. Disord.,2014

3. The most bothersome aspects of off periods reported by individuals with Parkinson's disease;Chahine;Movement disorders clinical practice,2020

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for general neurologists for qualification to device-aided therapies in advanced Parkinson’s Disease?;Neurologia i Neurochirurgia Polska;2024-08-28

2. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”;BMC Neurology;2024-07-30

3. Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies;Journal of Neural Transmission;2024-07-15

4. Utilization of MANAGE-PD Tool in a Real-World Setting in Germany: A Cross-Sectional Study;Brain Sciences;2024-06-24

5. What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience;Journal of Neural Transmission;2024-05-15